For HIV-1–negative, at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1. See full Indication.
Access the resources below for additional details about APRETUDE, such as the full Prescribing Information, including Instructions for Use, and downloadable resources such as the dosing and administration guide, getting started guide, and more.
Resources for Healthcare Professionals

Prescribing Information
See the full Prescribing Information, including Boxed Warning, for APRETUDE

Readiness Consideration Checklist
Review clinical considerations for appropriate patients when prescribing APRETUDE and readying your practice
Dosing and Admin Guide
Learn more about dosing and administration steps for APRETUDE

Getting Started Overview
Get detailed information on getting started with prescribed APRETUDE
Implementation FAQs
Answers to frequently asked questions about implementing APRETUDE into your practice
Instructions for Use
A helpful tool for complete preparation and injection instructions

Instructions For Use Flashcard
See the Instructions for Use Flashcard for APRETUDE

Dosing and Administration Guide
Review Dosing and Administration Information for APRETUDE
Dosing and Admin Guide
Learn more about dosing and administration steps for APRETUDE

Healthcare Provider Brochure
Download the APRETUDE brochure for Healthcare Providers
APRETUDE Patient Discussion Guide
View the full APRETUDE Patient Discussion Guide Information
Implementation FAQs
Answers to frequently asked questions about implementing APRETUDE into your practice
Instructions for Use
A helpful tool for complete preparation and injection instructions
Learn More About How to Prepare and
Administer APRETUDE
CBTWCNT220020